Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 19/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL634566 | 1.00 | UTS2R (0.71) | UTS2R | |
| SCHEMBL634388 | 0.92 | UTS2R (0.66) | UTS2R | |
| SCHEMBL634387 | 0.92 | UTS2R (0.66) | UTS2R | |
| SCHEMBL28783202 | 0.90 | UTS2R (0.68) | UTS2R | |
| SCHEMBL14949848 | 0.90 | UTS2R (0.68) | UTS2R | |
| SCHEMBL2345903 | 0.90 | UTS2R (0.75) | UTS2R | |
| SCHEMBL2343966 | 0.88 | UTS2R (0.71) | UTS2R | |
| SCHEMBL635170 | 0.88 | UTS2R (0.71) | UTS2R | |
| SCHEMBL635171 | 0.88 | UTS2R (0.71) | UTS2R | |
| SCHEMBL2345723 | 0.88 | UTS2R (0.80) | UTS2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079896-B2 | Urotensin II receptor antagonists | JANSSEN PHARMACEUTICA NV (BE) | 2015-07-14 | — | — | US | disclosed |
| EP-2326644-B1 | UROTENSIN II RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2012-02-22 | — | — | EP | disclosed |
| EP-2326644-A1 | UROTENSIN II RECEPTOR ANTAGONISTS | Janssen Pharmaceutica N.V. (BE) | 2011-06-01 | — | — | EP | disclosed |
| WO-2010017105-A1 | UROTENSIN II RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-02-11 | — | — | WO | disclosed |
| US-20100029616-A1 | UROTENSIN II RECEPTOR ANTAGONISTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029616-A1 | UROTENSIN II RECEPTOR ANTAGONISTS | UTS2R, PLAUR, BDKRB2 | UTS2R 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.